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Chronic visceral ischemia is an uncommon but
well recognized condition that is most often caused
by atherosclerotic narrowing of at least two of the
visceral arteries. Operative revascularization of both
major visceral arteries, the celiac artery and the supe-
rior mesenteric artery (SMA), is an effective and
durable treatment.1-4 Although there is no consensus
regarding the optimal operative approach, antegrade
aortovisceral bypass grafting or transaortic visceral
endarterectomy are our preferred revascularization
techniques.1 With these well-established techniques,
5-year cure and patency rates in excess of 85% have
been reported.1-3 Moreover, aortovisceral bypass
grafting or transaortic visceral endarterectomy are
also highly effective in the management of recurrent
visceral ischemia.5
However, in certain situations, revascularization
of both the celiac and SMA may not be feasible.
Extensive scar tissue or adhesions in patients with a
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Purpose: Complete visceral artery revascularization is recommended for the treatment of
chronic visceral ischemia. However, in rare cases, it may not be possible to revascularize
either the celiac or superior mesenteric (SMA) arteries. We have managed a series of
patients with isolated revascularization of the inferior mesenteric artery (IMA) and now
report our experience gained over a period of three decades.
Methods: Records were reviewed from 11 patients with chronic visceral ischemia who
underwent isolated IMA revascularization (n = 8) or who, because of failure of con-
comitant celiac or SMA repairs, were functionally left with an isolated IMA revascular-
ization (n = 3). All the patients had symptomatic chronic visceral ischemia documented
with arteriography. Five patients had recurrent visceral ischemia after failed visceral
revascularization, and two patients had undergone resection of ischemic bowel. The celi-
ac or the SMA was unsuitable for revascularization in five cases, and extensive adhesions
precluded safe exposure of the celiac or the SMA in five cases. IMA revascularization
techniques included: bypass grafting (n = 4), transaortic endarterectomy (n = 4), reim-
plantation (n = 2), and patch angioplasty (n = 1).
Results: There was one perioperative death, and the remaining 10 patients had cured or
improved conditions at discharge. One IMA repair thrombosed acutely but was success-
fully revascularized at reoperation. The median follow-up period was 6 years (range, 1
month to 13 years). Two patients had recurrent symptoms develop despite patent IMA
repairs and required subsequent visceral revascularization; interruption of collateral cir-
culation by prior bowel resection may have contributed to recurrence in both patients.
Objective follow-up examination with arteriography or duplex scanning was available
for eight patients at least 1 year after IMA revascularization, and all underwent patent
IMA repairs. There were no late deaths as a result of bowel infarction.
Conclusion: Isolated IMA revascularization may be useful when revascularization of
other major visceral arteries cannot be performed and a well-developed, intact IMA col-
lateral circulation is present. In this select subset of patients with chronic visceral
ischemia, isolated IMA revascularization can achieve relief of symptoms and may be a
lifesaving procedure. (J Vasc Surg 1999;30:51-8.)
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history of recent abdominal surgery or visceral revas-
cularization may preclude safe exposure of these
arteries. Diffuse atherosclerotic disease or abnormal
arterial anatomy also may render the celiac or SMA
unacceptable for either bypass grafting or endarterec-
tomy. Under such circumstances, when the celiac or
SMA is not a candidate for revascularization, the infe-
rior mesenteric artery (IMA) may be the only recon-
structable vessel.
Over the past three decades, we have treated, in
eight patients, symptomatic chronic visceral ischemia
in which revascularization of the celiac and SMA was
not possible at the time of operation. As an alterna-
tive, isolated revascularization of the IMA was per-
formed, and these cases form the basis of this report.
We have also included three patients who, because of
failure of concomitant celiac or SMA repairs, were
functionally left with an isolated IMA revasculariza-
tion. These cases emphasize: (1) the ability of the
IMA to supply adequate blood flow to the abdomi-
nal viscera, and (2) the use of isolated IMA revascu-
larization in selected patients with symptomatic
chronic visceral ischemia who are not candidates for
more extensive visceral revascularization.
PATIENTS AND METHODS
Between 1969 and 1996, 117 patients with
chronic visceral ischemia underwent visceral artery
revascularization at the University of California at
San Francisco. Of these 117 patients, eight patients
(7%) underwent isolated revascularization of the
IMA and three patients (3%) were functionally left
with an isolated revascularization of the IMA
because of failure of concomitant celiac or SMA
repairs (Table I). All the patients included in this
study had a preoperative diagnosis of chronic viscer-
al ischemia. The underlying cause was atherosclerot-
ic disease in 10 of the 11 patients. There was one
pediatric patient, 9 years of age, with Alagille syn-
drome and chronic visceral ischemia as a result of
middle aortic syndrome. Specifically excluded were
patients who underwent IMA revascularization dur-
ing repair of aortic aneurysms or aortoiliac occlusive
disease. Follow-up data were collected from hospital
and clinic charts and with telephone interview of the
patients, their families, or referring physicians.
The patients ranged in age from 9 to 78 years
(median age, 62 years), and 10 (91%) were women.
The most common associated medical conditions
were hypertension (64%) and atherosclerotic coro-
nary artery disease (36%). Most patients had a histo-
ry of tobacco use (73%), and only one patient had
diabetes (9%).
All of the patients had a history of postprandial
epigastric pain, and several had nausea and vomiting.
Diarrhea or constipation was occasionally reported.
One patient had evidence of ischemic colitis with
endoscopy. The duration of symptoms before oper-
ation ranged from 1 to 30 months (median, 6
months), and most patients had documented weight
loss. Five of the patients had undergone prior oper-
ation for visceral ischemia. However, none had
undergone prior revascularization of the IMA. Two
patients had a recent history of bowel resection for
ischemia. All the patients in this series underwent
preoperative biplanar aortography and had evidence
of occlusion or severe stenosis of all three major vis-
ceral arteries (celiac, SMA, and IMA). Ten of the 11
patients had angiographic evidence of collateral flow
from the IMA or branches of the internal iliac arter-
ies to the SMA via large marginal or meandering
mesenteric arteries. One patient previously under-
went aortofemoral bypass grafting with bilateral
end-to-end anastomoses to the femoral arteries,
which excluded collateral flow from the IMA and
internal iliac arteries.
Eight patients underwent isolated revasculariza-
tion of the IMA. In six of these patients, complete
visceral revascularization, including revascularization
of both the celiac and SMA, had been planned but
could not be accomplished. Dense adhesions result-
ing from prior bowel resection or visceral revascular-
ization precluded safe exposure of the celiac or SMA
in three cases. In the other three cases, the celiac and
SMA were inadequate targets for revascularization
because of diminutive size or the presence of long
fibrotic or calcified occlusions. Isolated IMA revascu-
larization was planned before surgery in two patients.
One of these patients had an occluded aortoceliac
bypass graft and an occluded native SMA and was a
poor surgical candidate because of severe chronic
obstructive pulmonary disease. The other patient had
middle aortic syndrome and a history of chronic vis-
ceral ischemia as a result of occlusion of a small celi-
ac and SMA and stenosis of the IMA, which supplied
the abdominal viscera via large collaterals. This
patient had subacute visceral ischemia develop and
underwent emergent isolated IMA revascularization.
Three patients underwent revascularization of
celiac (n =2) or both celiac and SMA (n = 1) in
addition to revascularization of the IMA. Because
of perioperative failure of the celiac or SMA
repairs, however, these patients were functionally
left with an isolated IMA revascularization. In
each of these cases, patency of the IMA revascu-
larization and restenosis or occlusion of the celiac
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or SMA revascularizations was documented with
postoperative angiography.
IMA revascularization techniques included
bypass grafting (n = 4; Fig 1), transaortic throm-
boendarterectomy (n = 4; Fig 2), reimplantation
into the aorta (n = 1) or the left common iliac artery
(n = 1), and patch angioplasty (n = 1). Three IMA
bypass grafts originated from the left common iliac
artery, and one originated from the left limb of an
aortofemoral bypass graft. Prosthetic grafts were
used in three patients, and reversed saphenous vein
was used in the other.
RESULTS
Isolated IMA revascularization achieved relief of
chronic visceral ischemia symptoms in all 10 surviving
patients. There was one postoperative death in a
patient who underwent left common iliac artery to
IMA bypass grafting. One day after discharge from
the hospital, this patient had severe diarrhea and was
readmitted with marked dehydration, hypotension,
and abdominal pain. Reexploration revealed extensive
bowel infarction, despite a patent IMA bypass graft.
Postoperative complications occurred in seven
patients. Morbidity included atelectasis, respiratory
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Table I. Inferior mesenteric artery revascularization for chronic visceral ischemia
Age Preoperative Prior visceral Reason(s) precluding
(years) Sex angiography revascularization Operation standard operation Outcome
9 M occlusion Ce/SMA; No IMA reimplant Ao middle aortic syndrome 20 months ASX
stenosis IMA and inadequate targets
65 F occlusion Ce/SMA; No Ao-IMA BP (PTFE) inadequate targets 36 months ASX
stenosis IMA
46 F occlusion Ce BP/SMA; Yes, Ao-Ce BP TA TEA IMA adhesions/scar recurrent SX 
stenosis IMA relieved by Ao-
SMA BP; IMA 
patent 22 months 
later
62 F occlusion Ce BP/SMA; Yes, Ao-Ce BP TA TEA IMA inadequate targets 129 months ASX
stenosis IMA
52 F occlusion Ce/SMA; No L CIA-IMA BP adhesions/scar 19 months ASX
stenosis IMA No (Dacron)
76 F occlusion Ce BP/SMA; Yes, Ao-Ce BP L limb AFBG-IMA severe COPD and 33 months ASX
AFBG excluded IMA BP (Dacron) adhesions/scar
75 F occlusion Ce; stenosis No L CIA-IMA BP inadequate targets 19 days; died of
SMA/IMA (Dacron) and Ao unsafe to clamp bowel infarction 
despite patent 
IMA BP
71 F occlusion Ce/SMA/IMA Yes, TA TEA TA TEA IMA adhesions/scar 2 months ASX; 
Ce/SMA revised on POD 7
to Ao-IMA BP 
(saphenous vein)
52 F occlusion Ce/SMA BP; Yes, SMA TEA Ao-Ce BP; IMA adhesions/scar (from recurrent SX; 146
stenosis IMA followed by reimplant L CIA* prior SMA operations) months ASX after




52 F occlusion Ce/SMA; No Ao-Ce BP, Ao-SMA — 156 months ASX
stenosis IMA BP, patch angioplasty 
IMA†
67 F occlusion SMA; stenosis No TA TEA Ce, TA inadequate target (SMA) 76 months ASX; 
Ce/IMA TEA IMA‡ recurrent SX from 
Ao “coral reef”; 
now 36 months 
ASX after TEA Ao
Ce, Celiac artery; SMA, superior mesenteric artery; IMA, inferior mesenteric artery; BP, bypass graft; AFBG, aortofemoral bypass graft;
Ao, aorta; TA TEA, transaortic thromboendarterectomy; PTFE, polytetrafluoroethylene; L CIA, left common iliac artery; COPD, chron-
ic obstructive pulmonary disease; ASX, asymptomatic; SX, symptoms; POD, postoperative day.
*Celiac bypass graft severely stenotic after surgery; inferior mesenteric artery supplied superior mesenteric artery circulation via collater-
als. Celiac to superior mesenteric artery collaterals interrupted by prior bowel resection.
†Celiac bypass graft and superior mesenteric artery bypass graft occluded after surgery; inferior mesenteric artery supplied all viscera via
collaterals.
‡Celiac severely stenotic after surgery; inferior mesenteric artery supplied all viscera via collaterals.
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Fig 1. Inferior mesenteric artery (IMA) bypass graft. A, Preoperative aortogram with occlu-
sion of celiac and superior mesenteric arteries and high-grade stenosis of IMA (arrow). B,
Postoperative angiogram after aorta to IMA bypass graft with reversed saphenous vein (arrow).
Fig 2. Transaortic inferior mesenteric artery (IMA) endarterectomy. A, Preoperative arteri-
ogram reveals celiac and superior mesenteric artery occlusions and severe IMA stenosis
(arrow). B, Widely patent IMA (arrow) after transaortic IMA endarterectomy.
failure necessitating reintubation, prolonged ileus,
sepsis, and bleeding necessitating reexploration.
Arterial dissection and thrombosis after transaortic
endarterectomy of the IMA occurred in one case
and was detected with routine angiography on post-
operative day 7. Revision with a reversed saphenous
vein bypass graft from the aorta to the IMA was per-
formed, and the patient was later discharged with
relief of postprandial pain.
Follow-up period ranged from 1 month to 13
years (median, 6 years). Six patients died during the
follow-up period, with no deaths known to be the
result of intestinal infarction. Recurrent visceral
ischemia developed in two patients with a history of
recent intestinal resection. In both cases, dense adhe-
sions caused by laparotomy and intestinal resection
within the previous 6 weeks prohibited safe exposure
of the celiac and the SMA. At reoperation several
months later, however, exposure of the suprarenal
aorta and antegrade bypass grafting to the celiac or
the SMA was possible. Both patients were thereafter
asymptomatic. Another patient was seen 6 years after
transaortic IMA endarterectomy with recurrent
symptoms as a result of an occlusive “coral reef”
lesion of the intervening infrarenal aorta. The IMA
remained widely patent, and endarterectomy of the
infrarenal aorta relieved the patient’s visceral ischemia
symptoms (Fig 3).
Objective follow-up examination with arteriogra-
phy or duplex scanning was available for eight
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Fig 3. Recurrent visceral ischemia after inferior mesenteric artery (IMA) revascularization as
result of aortic coral reef lesion. A, Preoperative IMA stenosis (arrow). B, Widely patent IMA
after transaortic endarterectomy. C, Recurrent visceral ischemia 5 years later as result of occlu-
sive coral reef lesion of aorta (large arrow), which limited flow through patent IMA (small
arrow). D, Endarterectomy of infrarenal aorta restored visceral perfusion via large meandering
vessel (arrow) from IMA.
patients at least 1 year after IMA revascularization.
All eight patients had patent IMA revascularizations
with evidence of collateral flow from the IMA to the
SMA circulation via marginal or meandering mesen-
teric vessels. Serial mesenteric duplex scanning has
been used to follow three IMA revascularizations,
and, in all cases, significant increases in postprandial
flow suggest the lack of a high-grade stenosis.
DISCUSSION
Controversy persists regarding the number of
visceral vessels that should be revascularized for the
treatment of chronic visceral ischemia. Hollier et al6
reported recurrence rates of up to 50% when only a
single visceral artery was revascularized and suggest-
ed that frequency of recurrent visceral ischemia
symptoms is inversely related to the extent of viscer-
al revascularization. On the basis of similar observa-
tions, many investigators promote revascularization
of at least the two major visceral arteries, the celiac
and the SMA.2,3,7,8 Nonetheless, low rates of recur-
rent visceral ischemia after isolated SMA9 or after
isolated celiac revascularization10 have also been
reported. To minimize the chances of symptomatic
recurrent visceral ischemia, however, we favor multi-
vessel revascularization with the established tech-
niques of antegrade aortovisceral bypass grafting or
transaortic endarterectomy.1,10 Although multives-
sel visceral revascularization with established tech-
niques is possible in most cases, including reopera-
tion for recurrent visceral ischemia,5 we have
encountered a group of patients with chronic viscer-
al ischemia who were not candidates for revascular-
ization of the celiac or SMA. In these difficult cases,
isolated revascularization of the IMA was performed
with subsequent relief of chronic visceral ischemia
symptoms in eight of the 10 surviving patients.
Moreover, there were no late deaths caused by
bowel infarction. Our results, which represent the
first reported series of isolated IMA revascularization
for the treatment of chronic visceral ischemia, sug-
gest that this approach is an acceptable alternative
when celiac or SMA revascularization is not feasible.
Our results also show that, in patients with steno-
sis or occlusion of the major visceral arteries, collat-
eral flow from the IMA is often sufficient to relieve
intestinal angina and prevent clinically significant
bowel ischemia. The IMA or collateral vessels from
the pelvic arteries are often the critical source of
intestinal blood flow in chronic visceral ischemia, and
filling of the SMA or celiac via collaterals from the
IMA is frequently observed during angiography in
patients with visceral artery occlusive disease.11 The
celiac, SMA, and IMA circulations communicate
through several major anastomotic pathways.12
Connections between the colic arteries form the mar-
ginal artery of Drummond, which lies close to the
mesocolic border. The more centrally located arc of
Riolan is formed by branches of the middle and left
colic arteries and often appears as a large meandering
mesenteric artery in patients with visceral artery
occlusive disease. Collateral flow between the SMA
and celiac circulations is mainly through the gastro-
duodenal and the pancreaticoduodenal arteries. A
direct communication between the SMA and celiac
arteries, the arc of Bühler, is also present in occasion-
al patients. The importance of collateral intestinal
flow from the IMA has also been studied in the con-
text of aortic reconstruction, where colonic or
intestinal infarction is a well-recognized, albeit infre-
quent, complication after aortic aneurysmectomy or
aortofemoral bypass grafting for aortoiliac occlusive
disease.13,14 Ligation of the IMA during aortic
surgery may be catastrophic in patients with impaired
visceral blood supply. In such cases, IMA revascular-
ization or concomitant visceral revascularization will
reduce the incidence of colon ischemia.15
Symptoms of chronic visceral ischemia recurred
in two patients after isolated IMA revascularization,
possibly as a result of the interruption of normal
mesenteric collaterals by prior intestinal resection.
Major anastomotic pathways between the visceral
arteries are divided during gastric or intestinal resec-
tion. Despite widely patent IMA repairs with
angiography, both patients required subsequent
revascularization of either the celiac or the SMA to
establish adequate visceral blood flow. Our results
suggest that isolated IMA revascularization requires
both well-developed and intact collateral pathways
to provide blood flow to all abdominal viscera.
Therefore, after gastric or intestinal resection, multi-
vessel revascularization should be performed.
Importantly, although exposure of the celiac and
SMA may not be possible at times because of exten-
sive adhesions, more complete visceral revasculariza-
tion is often possible several months later, when
edema and dense adhesions have resolved. In this
setting, isolated IMA revascularization may be a use-
ful temporizing measure until a more definitive pro-
cedure can be performed.
The advent of new percutaneous techniques may
afford an alternative to operative visceral revascular-
ization in selected cases.16,17 Although the durability
of visceral angioplasty and stenting remains unproved,
these techniques may be useful when scar or adhe-
sions preclude safe surgical exposure of either the celi-
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ac or SMA. Half of our patients, however, underwent
isolated IMA revascularization because of the small
caliber of the celiac or SMA or the presence of long
fibrotic or calcified occlusions of these vessels. It is
unlikely that visceral angioplasty would have provided
any additional benefit in these patients.
Our preferred approach to the treatment of
chronic visceral ischemia remains surgical revascular-
ization of both the celiac and SMA whenever possi-
ble. In selected cases, however, when antegrade aor-
tovisceral bypass grafting or transaortic endarterec-
tomy of the celiac or SMA is not possible because of
technical or patient-related factors, isolated IMA
revascularization may supply adequate blood flow to
the abdominal viscera. In the presence of well-devel-
oped mesenteric collaterals, IMA revascularization
can provide relief of ischemic symptoms and be a
lifesaving procedure.
We thank Drs Ronald Stoney and Douglas Grey gen-
erously for their contribution of several cases to this series.
We also thank Andrea Lemmo, BSN, for assistance with
data collection and patient follow–up.
REFERENCES
1. Cunningham CG, Reilly LM, Rapp JH, Schneider PA,
Stoney RJ. Chronic visceral ischemia. Three decades of
progress. Ann Surg 1991;214:276-87.
2. McMillan WD, McCarthy WJ, Bresticker MR, Pearce WH,
Schneider JR, Golan JF, et al. Mesenteric artery bypass: objec-
tive patency determination. J Vasc Surg 1995;21:729-41.
3. Johnston KW, Lindsay TF, Walker PM, Kalman PG.
Mesenteric arterial bypass grafts: early and late results and
suggested surgical approach for chronic and acute mesenteric
ischemia. Surgery 1995;118:1-7.
4. Rheudasil JM, Stewart MT, Schellack JV, Smith RB III,
Salam AA, Perdue GD. Surgical treatment of chronic mesen-
teric arterial insufficiency. J Vasc Surg 1988;8:495-500.
5. Schneider DB, Schneider PA, Reilly LM, Ehrenfeld WK,
Messina LM, Stoney RJ. Reoperation for recurrent chronic
visceral ischemia. J Vasc Surg 1998;27:276-86.
6. Hollier LH, Bernatz PE, Pairolero PC, Payne WS, Osmundson
PJ. Surgical management of chronic intestinal ischemia: a reap-
praisal. Surgery 1981;90:940-6.
7. Calderon M, Reul GJ, Gregoric ID, Jacobs MJ, Duncan JM,
Ott DA, et al. Long-term results of the surgical management
of symptomatic chronic intestinal ischemia. J Cardiovasc Surg
(Torino) 1992;33:723-8.
8. McAfee MK, Cherry KJ Jr, Naessens JM, Pairolero PC,
Hallett JW Jr, Gloviczki P, et al. Influence of complete revas-
cularization on chronic mesenteric ischemia. Am J Surg
1992;164:220-4.
9. Gentile AT, Moneta GL, Taylor LM Jr, Park TC, McConnell
DB, Porter JM. Isolated bypass to the superior mesenteric
artery for intestinal ischemia. Arch Surg 1994;129:926-31.
10. Stoney RJ, Ehrenfeld WK, Wylie EJ. Revascularization meth-
ods in chronic visceral ischemia caused by atherosclerosis.
Ann Surg 1977;186:468-76.
11. Zelenock GB, Graham LM, Whitehouse WM Jr, Erlandson
EE, Kraft RO, Lindenauer SM, et al. Splanchnic arterioscle-
rotic disease and intestinal angina. Arch Surg 1980;115:
497-501.
12. Rosenblum JD, Boyle CM, Schwartz LB. The mesenteric cir-
culation. Anatomy and physiology. Surg Clin North Am
1997;77:289-306.
13. Ernst CB. Prevention of intestinal ischemia following
abdominal aortic reconstruction. Surgery 1983;93:102-6.
14. Crowson M, Fielding JW, Black J, Ashton F, Slaney G. Acute
gastrointestinal complications of infrarenal aortic aneurysm
repair. Br J Surg 1984;71:825-8.
15. Zelenock GB, Strodel WE, Knol JA, Messina LM, Wakefield
TW, Lindenauer SM, et al. A prospective study of clinically
and endoscopically documented colonic ischemia in 100
patients undergoing aortic reconstructive surgery with
aggressive colonic and direct pelvic revascularization, com-
pared with historic controls. Surgery 1989;106:771-9.
16. Rose SC, Quigley TM, Raker EJ. Revascularization for
chronic mesenteric ischemia: comparison of operative arterial
bypass grafting and percutaneous transluminal angioplasty. J
Vasc Interv Radiol 1995;6:339-49.
17. Allen RC, Martin GH, Rees CR, Rivera FJ, Talkington CM,
Garrett WV, et al. Mesenteric angioplasty in the treatment of
chronic intestinal ischemia. J Vasc Surg 1996;24:415-21.
Submitted Sep 15, 1998; accepted Nov 25, 1998.
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 1 Schneider et al 57
Dr Timothy Harward (Orange, Calif). This simple,
retrospective review of 11 patients addresses a question
that can only be appreciated by individuals who follow a
large population of patients previouly treated for chronic
mesenteric ischemia. The initial optimal therapy is surgical
revascularization. My preference, like the authors, is a
supraceliac aorta to celiac axis/superior mesenteric artery
bypass graft with a bifurcated Dacron graft. This recon-
struction has been found to be durable; however, there are
still failures because of progression of the atherosclerotic
disease process distally into the far reaching mesenteric
branches. This problem, along with dense adhesions in the
region of the previous supraceliac procedure, makes it
both undesirable and frequently impossible to reenter this
area without injuring the stomach, esphagus, or liver.
Because I have followed well over 40 patients after recon-
struction along with attempting to “redo” the supracelial
reconstruction, I too began to contemplate other methods
to maintain visceral perfusion. I too arrived at the conclu-
sion that IMA/arc of Riolan revascularization might be a
viable option. One only needs to understand and visualize
on an aortogram the extensive visceral collateral network
DISCUSSION
in these patients to arrive at the concept of inferior mesen-
teric artery revascularization as a back-up procedure. It
was with this thought in mind that I eagerly anticipated
reviewing their manuscript. In fact, I believe this was
indeed the question they attempted to ask and did answer.
Yes, inferior mesenteric artery revascularization alone can
provide sufficient visceral perfusion to perserve intestinal
and hepatic physiologic function sufficient to maintain
normal body functions.
In addition, the authors have reaffirmed my belief that
single artery revascularization has poor durability, especial-
ly if the collateral network integrity is not intact. In my
opinion, single artery bypass grafting or balloon angioplas-
ty should only be done in desperate times when no other
options are available or as a bridge to a later, more definite
procedure. In this study, two patients who did well initial-
ly redeveloped intestinal angina at a later time; in these two
individuals, bowel resection was done, which disrupted the
integrity of the collateral network. Both patients under-
went later, more definitive supraceliac revascularizations.
All told, I have three questions. The morbidity rate in
your study was approximately 63%. Many would say this
rate is much too high; however, I find it to be expected. I
hold a strong conviction that much of the respiratory fail-
ure, prolonged ileus, and postoperative bleeding seen after
visceral revascularization is caused by an ischemia/reperfu-
sion phenomenon massive cytokine release causing exten-
sive capillary leakage, pulmonary sequestration of platelets
and white cells, etc. Question one, what are your thoughts
concerning this matter and, if doubt exists in your mind,
how do you account for this high morbidity rate?
I am also interested in your use of prosthetic versus
autogenous vein conduits to construct your IMA mesen-
teric bypass grafts. I have found prosthetic conduits to
have a much longer patency rate than autogenous vein.
Question two, has your group any thoughts on this idea,
and did it influence your decision process?
Finally, I noticed that your long-term mortality rate
was more than 50%. I have found that patients with chron-
ic mesenteric ischemia have a fairly good longevity in that
their incidence of coronary artery disease is quite low (25%
to 30%) compared with a 50% to 60% incidence in patients
with other atherosclerotic problems. Therefore, myocardial
infarctions are not a common problem during follow-up
despite the strong history of cigarette smoking. Question
three, what were the causes of death in your group, and
does the high mortality rate possibly represent the end of
the spectrum for patients who have fought a long battle
with the problem of chronic mesenteric artery insufficien-
cy and resulting visceral ischemia?
Dr Darren B. Schneider. Thank you, Dr Harward, for
your insightful comments and questions. In answer to your
first question, I agree that our morbidity rate of about 63%
appears high. Although we have not specifically addressed
the issue of reperfusion injury, your hypothesis that after
visceral reperfusion multiple organ dysfunction occurs as a
result of systemic release of inflammatory mediators is
probably correct. We did have several patients who experi-
enced postoperative respiratory failure. Moreover, the fact
that we observed frequent complications may indicate that
isolated IMA revascularization was sufficient to restore per-
fusion to chronically ischemic bowel.
Your second question addressed our choice of conduit
for visceral artery bypass grafts. We usually perform either
transaortic endarterectomy or antegrade aortovisceral bypass
grafting with prosthetic grafts to treat chronic visceral
ischemia. In our experience, prosthetic grafts function quite
well in the visceral circulation. Because a relatively short seg-
ment of conduit is used when bypass grafts are placed in an
antegrade orientation and because the visceral circulation has
high blood flow rates, the long-term patency of prosthetic
bypass grafts is excellent. For these reasons, we elected to use
prosthetic grafts for IMA revascularization.
Finally, you also asked about our long-term mortality
rate of more than 50%. Because our series contains cases
accumulated over almost 30 years, it is not surprising that
more than 50% of our patients are no longer alive. The
causes of death included myocardial infarction in one
patient, metastatic cancer in two patients, and stroke in
another patient. One patient died after electing to termi-
nate hemodialysis. I do not believe that the mortality rate
necessarily “represents the end of the spectrum” of chron-
ic visceral ischemia because none of the late deaths were
known to be caused by bowel infarction. On the other
hand, several of our patients underwent isolated IMA
revascularization because other visceral revascularization
options had been exhausted. In these patients, IMA revas-
cularization was probably a lifesaving procedure.
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